Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.71 - $2.62 $52,839 - $80,958
-30,900 Reduced 65.05%
16,600 $33,000
Q2 2024

Aug 15, 2024

BUY
$1.97 - $3.62 $61,858 - $113,668
31,400 Added 195.03%
47,500 $95,000
Q1 2024

May 07, 2024

BUY
$1.18 - $2.71 $18,998 - $43,631
16,100 New
16,100 $43,000
Q3 2023

Nov 14, 2023

BUY
$1.39 - $1.72 $21,267 - $26,316
15,300 New
15,300 $24,000

Others Institutions Holding INCR

About Intercure Ltd.


  • Ticker INCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,133,900
  • Market Cap $75.8M
  • Description
  • InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 a...
More about INCR
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.